Because this is a recently recognized adverse effect, treatment strategies are drawn from case report outcomes, general allodynia management guidelines, and clinical experience with neuropathic pain
Food and Drug Administration (FDA) for human use or medical treatment
The limitation in these trials is muscle mass
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus
Refrigeration slows these reactions down dramatically, extending the peptide's useful life from a few days to several weeks or even months, depending on the concentration and handling